Smaller airway clearing vest gets FDA nod:
This article was originally published in Clinica
Advanced Respiratory has gained US clearance to market a smaller and more portable version of its inflatable vest-like device for improving airflow to the lungs in patients with respiratory conditions. The Vest model 104, for use at home, is designed to replace manual chest physical therapy. It employs high-frequency chest wall oscillation technology that moves mucus from smaller airways into larger ones, where it can be cleared by coughing or suctioning. Weighing just 17lbs, the new model is half the weight and a third of the size of its predecessor, says the St Paul, Minnesota firm.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.